NexgenRx Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported revenue was CAD 12.78 million compared to CAD 11.84 million a year ago. Net loss was CAD 0.022401 million compared to net income of CAD 4.02 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.23 CAD | 0.00% | +4.55% | +4.55% |
05/04 | NexgenRx Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | NEXGENRX INC. Announces the Retirement of Dave Bennett from its Board of Directors | CI |
1st Jan change | Capi. | |
---|---|---|
+4.55% | 11.92M | |
+1.80% | 93.1B | |
+13.81% | 68.97B | |
+17.46% | 63.84B | |
+12.10% | 43.64B | |
+13.22% | 42.71B | |
+16.60% | 34.03B | |
+3.35% | 24.85B | |
-1.55% | 22.97B | |
+6.13% | 19.57B |
- Stock Market
- Equities
- NXG Stock
- News NexgenRx Inc.
- NexgenRx Inc. Reports Earnings Results for the Full Year Ended December 31, 2022